Animals cope with climate change at the dinner table
| 2/9/2010 | Some animals, it seems, are going on a diet, while others have expanding waistlines. It's likely these are reactions to rapidly rising temperatures due to global climate change, speculates Prof. Yoram Yom-Tov of Tel Aviv University's Department of Zoology, who has been measuring the evolving body sizes of birds and animals in areas where climate change is most extreme. Changes are happeni... [Comments] |
Flower power can still calm the masses
| 2/9/2010 | Feeling stressed? Try chamomile! This 'traditional' remedy has been around for years, but how much truth is there behind this old wives' tale? In an evaluation for Faculty of 1000, Michael Van Ameringen and Beth Patterson draw attention to the first randomized controlled trial of chamomile for the treatment of generalized anxiety disorder (GAD). The study, recently published in the Journ... [Comments] |
New international satellite observations help assess future earthquake risk in Haiti
| 2/9/2010 | Virginia Key, Florida--Scientists at the University of Miami have analyzed images based on Synthetic Aperture Radar (SAR) observations taken before and just after Haiti's earthquake, on January 12. The images reveal surprising new details. The images were obtained using data from Japan's... [Comments] | ![]() |
New study examines the impact on children of food product placements in the movies
| 2/9/2010 | LEBANON, NH- (February 5, 2010) New research from the Hood Center for Children and Families at Dartmouth Medical School (DMS) for the first time sheds light on the significant potential negative impact that food product placements in the movies could be having on children. The study, which appears in the current edition of the journal Pediatrics , shows that most of the "brand placements"... [Comments] |
Anorexics found to have excess fat-- in their bone marrow
| 2/9/2010 | Boston, Mass.-- People with anorexia nervosa, paradoxically, have strikingly high levels of fat within their bone marrow, report researchers at Children's Hospital Boston. Their findings, based on MRI imaging of the knees of 20 girls with anorexia and 20 healthy girls of the same age, appear in the February issue of the Journal of Bone and Mineral Research . "It's counter-intuitive that an... [Comments] |
Comprehensive study using bioinformatics predicts the molecular causes of many genetic diseases
| 2/9/2010 | It is widely known that genetic mutations cause disease. What are largely unknown are the mechanisms by which these mutations wreak havoc at the molecular level, giving rise to clinically observable symptoms in patients. Now a new study using bioinformatics, led by scientists at the Buck Institute for Age Research, reports the ability to predict the molecular cause of many inherited genetic d... [Comments] |
Scripps research team reveals how an old drug could have a new use for treating river blindness
| 2/9/2010 | LA JOLLA, CA--Scientists at The Scripps Research Institute have discovered a potential new use for the drug closantel, currently the standard treatment for sheep and cattle infected with liver fluke. The new research suggests that the drug may be useful in combating river blindness, a tropical disease that is the world's second leading infectious cause of blindness for humans. The study i... [Comments] |
Modeling Toxoplasma focus of workshop
| 2/9/2010 | Toxoplasma gondii ( T. gondii ) is considered as one of the most successful parasites for its unusual ability to infect a wide range of intermediate hosts, including all mammals and birds. Up to 11% of the human population in the US and 20% in the world are chronically infected. The National Institute for Mathematical and Biological Synthesis (NIMBioS) is now accepting applications for... [Comments] |
Mouse Anti-Snail, a.a. 150-39 Antibody, Unconjugated from CHEMICON
Description:Snail, a.a. 150-39...Rat Anti-Mouse IgM Heavy Chain Monoclonal Antibody, Unconjugated, Clone LO-MM-3 from Cell Sciences
Description:Anti-Mouse IgM Heavy Chain, Clone LO-MM-3, Monoclonal Antibody...Chicken Anti-HOXC11 Polyclonal Antibody, Unconjugated from ProSci, Inc
Description:HOXC11 Antibody...Rabbit Anti-BAFF-R (CT) BR3 Polyclonal Antibody, Unconjugated from ProSci, Inc
Description:BAFF-R (CT) BR3 Affinity Purified Polyclonal Antibody...Chicken Anti-HOXC11 Polyclonal Antibody, Unconjugated from ProSci, Inc
Description:HOXC11 Antibody...| 2/9/2010 | NEW YORK , Feb. 9 Reportlinker.com announces that a new market research report is available in its catalogue: The Clinical Laboratory Services Market (Growth Opportunities, Competitive Analysis and Competitor Profiles) http://www.reportlinker.com/p0176223/The-Clinical-Laboratory-Services-Market-Growth-Opportunities-Competitive... [Comments] |
Reportlinker Adds SNP Genotyping and Analysis Markets
| 2/9/2010 | NEW YORK , Feb. 9 Reportlinker.com announces that a new market research report is available in its catalogue: SNP Genotyping and Analysis Markets http://www.reportlinker.com/p0176225/SNP-Genotyping-and-Analysis-Markets.html Because SNPs (single nucleotide polymorphisms),are the most common type of genetic variation betw... [Comments] |
endpoint Saves Money and Time for Medical Research Teams Through PULSE
| 2/9/2010 | SAN FRANCISCO , Feb. 9 endpoint Clinical ( www.endpointclinical.com ), a leader in Integrated Voice Response (IVR)/Integrated Web Response (IWR) systems, announced today that PULSE, a fully configurable platform that allows users to design and deploy clinical trial Integrated Response Technology (IRT) systems, saves 40 percent on the development time of c... [Comments] |
Ardea Biosciences Announces Appointment of Felix J. Baker, Ph.D. to Board of Directors
| 2/9/2010 | SAN DIEGO , Feb. 9 Ardea Biosciences, Inc. (Nasdaq: RDEA ) today announced that Felix J. Baker , Ph.D., has been appointed to the Company's Board of Directors. Dr. Baker is a managing partner of Baker Bros. Advisors, LLC, the manager and advisor to the funds of Baker Brothers Investments, Ardea's largest shareholder. "Ardea's impr... [Comments] |
| 2/9/2010 | CHENGDU, China , Feb. 9 /PRNewswire-Asia-FirstCall/ -- TianyinPharmaceutical Co., Inc., (NYSE Amex: TPI ), a manufacturer and supplier ofmodernized traditional Chinese medicine ("TCM") and Western Pharmaceuticalsbased in Chengdu, China , today announced that it expects operational benefitsfrom the recently published Guide to Reform of Pricing Mechanism... [Comments] |